ReviewJournal of clinical medicine2025

Safety and Efficacy of Achieving Very Low LDL Cholesterol Concentrations with PCSK9 Inhibitors.

Akshay Machanahalli Balakrishna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.